Denali Therapeutics’ $400 Million At-The-Market Offering

Laura Testa North America Legal Chronicle
Tagged:

Davis Polk advised the sales agents in the transaction.The transaction consists in a new SEC-registered at-the-market offering program by Denali Therapeutics Inc. under which Denali may…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here